New Pathways for Alimentary Mucositis

Abstract EN

Alimentary mucositis is a major dose-limiting toxicity associated with anticancer treatment.

It is responsible for reducing patient quality of life and represents a significant economic burden in oncology.

The pathobiology of alimentary mucositis is extremely complex, and an increased understanding of mechanisms and pathway interactions is required to rationally design improved therapies.

This review describes the latest advances in defining mechanisms of alimentary mucositis pathobiology in the context of pathway activation.

It focuses particularly on the recent genome-wide analyses of regimen-related mucosal injury and the identification of specific regulatory pathways implicated in mucositis development.

This review also discusses the currently known alimentary mucositis risk factors and the development of novel treatments.

Suggestions for future research directions have been raised.